Quantitative analysis of 7-hydroxymitragynine in commercial kratom products and its stability under chemical and physiological conditions
Phytochemistry · 2026
DOI: 10.1016/j.phytochem.2026.114871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2026. Verfasst von Bharathi Avula und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, United States. Hauptthemen laut MEDLINE: Mitragyna, Secologanin Tryptamine Alkaloids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Food Safety and Applied Nutrition, US Food and Drug Administration.
Abstract (Originalsprache)
7-Hydroxymitragynine (7-OH), a minor alkaloid in kratom (Mitragyna speciosa (Korth.) Havil.) (Rubiaceae) and an active metabolite of mitragynine, is a critical transient precursor to mitragynine pseudoindoxyl, which exhibits >2-fold μ-opioid receptor-biased agonism and improved isoform selectivity relative to its precursors. Although present only in trace amounts in kratom leaves, a recent survey identified hundreds of consumer products with semisynthetic 7-OH and mitragynine pseudoindoxyl. Their high potency, ease of access, and risk of addiction have prompted the US FDA to recommend scheduling 7-OH as a Schedule I controlled substance. To address this public health crisis and the associated analytical challenges, a comprehensive analysis of commercially available kratom products was performed. The results revealed substantial inconsistencies between the quantities claimed on the products' labels and the actual 7-OH amount detected in several of these products. Along with 7-OH and mitragynine pseudoindoxyl, several (over)oxidized byproducts were detected, providing crucial insights into their synthetic origins. Analysis of >98% of 7-OH-labeled products indicated a semisynthetic origin, with labeled doses ranging from 0.001 to 33.6 mg per serving. Furthermore, consistent with the prior report, 7-OH degrades into the potentially toxic byproduct 3-dehydromitragynine under simulated gastric conditions. These findings underscore significant safety concerns over oral 7-OH products and necessitate validated analytical monitoring to guide regulatory oversight and consumer protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, United States.
- Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, United States.
- National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, Mississippi 38677-1848, United States; Department of BioMolecular Sciences, School of Pharmacy, University of Mis…
Förderung
- Center for Food Safety and Applied Nutrition
- US Food and Drug Administration
Zitieren
APA
Avula, B., Ali, S. K., Tatapudi, K. K., Pandey, P., Cheepilla, L., Husain, I., Khan, S. I., Katragunta, K., Ali, Z., Khan, I. A., & Chittiboyina, A. G. (2026). Quantitative analysis of 7-hydroxymitragynine in commercial kratom products and its stability under chemical and physiological conditions. Phytochemistry. https://doi.org/10.1016/j.phytochem.2026.114871
Vancouver
Avula B, Ali SK, Tatapudi KK, Pandey P, Cheepilla L, Husain I, et al. Quantitative analysis of 7-hydroxymitragynine in commercial kratom products and its stability under chemical and physiological conditions. Phytochemistry. 2026. doi:10.1016/j.phytochem.2026.114871
BibTeX
@article{Avula2026,
author = {Avula, Bharathi and Ali, Syed Kashif and Tatapudi, Kiran K and Pandey, Pankaj and Cheepilla, Lochana and Husain, Islam and Khan, Shabana I and Katragunta, Kumar and Ali, Zulfiqar and Khan, Ikhlas A and Chittiboyina, Amar G},
title = {Quantitative analysis of 7-hydroxymitragynine in commercial kratom products and its stability under chemical and physiological conditions},
journal = {Phytochemistry},
year = {2026},
doi = {10.1016/j.phytochem.2026.114871}
}
EUVIMED